Benchmark study: Exiqon mircury LNA microrna arrays vs. Supplier A s DNA based capture probes. Includes comparison of:

Similar documents
microrna PCR System (Exiqon), following the manufacturer s instructions. In brief, 10ng of

SC-L-H shared(37) Specific (1)

Supplementary materials and methods.

Synthetic microrna Reference Standards Genomics Research Group ABRF 2015

A novel and universal method for microrna RT-qPCR data normalization

developing new tools for diagnostics Join forces with IMGM Laboratories to make your mirna project a success

A two-microrna signature in urinary exosomes for diagnosis of prostate cancer

Correspondence: mirna regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration

Patnaik SK, et al. MicroRNAs to accurately histotype NSCLC biopsies

mirna Whole Transcriptome Assay

sirna count per 50 kb small RNAs matching the direct strand Repeat length (bp) per 50 kb repeats in the chromosome

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

mirna-guided regulation at the molecular level

CONTRACTING ORGANIZATION: University of Southern California Los Angeles, CA 90033

microrna Presented for: Presented by: Date:

Discovery of mirna cancer biomarkers

On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles

MicroRNAs: novel regulators in skin research

Bi 8 Lecture 17. interference. Ellen Rothenberg 1 March 2016

CONTRACTING ORGANIZATION: University of Mississippi Medical Center Jackson, MS 39216

2 nd international conference On translational and personalized Medecine OMICS group Chicago 5 th to 7 th August, 2013

microrna-guided diagnostics for neuroendocrine tumors

Set the stage: Genomics technology. Jos Kleinjans Dept of Toxicogenomics Maastricht University, the Netherlands

micrornas (mirna) and Biomarkers

In Situ Hybridization: Market Strategies and Forecasts, US,

DETECTING DISEASE IN BLOOD

Electronic Supplementary Information. Direct chemiluminescence detection of circulating. micrornas in serum samples using a single-strand specific

Micro RNA Research. Ken Kosik. Harriman Professor, Department of Molecular, Cellular & Developmental Biology and Biomolecular Sciences & Engr.

he micrornas of Caenorhabditis elegans (Lim et al. Genes & Development 2003)

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

TITLE: Laser Capture Microdissection Assisted Identification of Epithelial MicroRNA Expression Signatures for Prognosis of Stage I NSCLC

Circulating Microrna Expression As A Biomarker For Early Diagnosis Of Severity In Spinal Cord Injury

资料来自互联网, 仅供科研和教学使用, 使用者请于 24 小时内自行删除

SUPPLEMENTAY FIGURES AND TABLES

Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent Protein.

A meta-analysis of the effect of microrna-34a on the progression and prognosis of gastric cancer

Acute myocardial infarction (MI) on initial presentation was diagnosed if there was 20 minutes

We used the kanamycin-resistant pneumococcal strain S. pneumoniae Xen10

From reference genes to global mean normalization

A sensitive non-radioactive northern blot method to detect small RNAs

SUPPLEMENTARY INFORMATION

Li-Xuan Qin 1* and Douglas A. Levine 2

Profiles of gene expression & diagnosis/prognosis of cancer Lorena Roa de la Cruz

Laboratory for Clinical and Biological Studies, University of Miami Miller School of Medicine, Miami, FL, USA.

Research Article Identification of Aberrantly Expressed mirnas in Gastric Cancer

P. Mathijs Voorhoeve, Carlos le Sage, Mariette Schrier, Ad J.M. Gillis, Hans Stoop,

Chapter 18. mirna Expression Profiling: From Reference Genes to Global Mean Normalization

ncounter TM Analysis System

A YAP/TAZ-miR-130/301 molecular. circuit exerts systems-level control of fibrosis in a network of. diseases and physiologic conditions

Analysis of mirna expression under stress in Arabidopsis thaliana

Identification of aberrantly expressed mirnas in rectal cancer

Prediction of micrornas and their targets

Original Article Circulating mir-665 and mir-30c-1-3p, the candidate markers of congestive heart failure with qi-deficiency-blood-stasis syndrome

Can the Gut Microbiome Control the Brain? Dr Gerard Clarke Department of Psychiatry and Neurobehavioural Science and APC Microbiome Ireland

Non-Invasive Array Based Screening for Cancer. Dr. Amit Kumar President and CEO CombiMatrix Corporation

RECENT ADVANCES IN THE MOLECULAR DIAGNOSIS OF BREAST CANCER

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS)

Solid-Phase Purification of Synthetic DNA Sequences. Serge L. Beaucage, Ph.D. Chief, Laboratory of Biological Chemistry FDA-CDER

Workflow. Connecting the Pieces For Total Patient Care

ARTICLE IN PRESS. Critical Reviews in Oncology/Hematology xxx (2010) xxx xxx

Circulating MicroRNAs in Patients with Active Pulmonary Tuberculosis

mirna Biomarkers Seena K. Ajit PhD Pharmacology & Physiology Drexel University College of Medicine October 12, 2017

Gene expression analysis. Roadmap. Microarray technology: how it work Applications: what can we do with it Preprocessing: Classification Clustering

Cellular MicroRNA and P Bodies Modulate Host-HIV-1 Interactions. 指導教授 : 張麗冠博士 演講者 : 黃柄翰 Date: 2009/10/19

Lombardi Cancer Center Georgetown University Washington, DC

MicroRNA in Cancer Karen Dybkær 2013

Laboratory Considerations

Positive expression of mir-361-5p indicates better prognosis for breast cancer patients

Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression.

Over the past decade, it has become progressively more

Musculoskeletal Diseases

SUPPLEMENTARY INFORMATION

microrna Therapeutics Heading Towards the Clinic

Original Article Differential expression profile analysis of mirnas with HER-2 overexpression and intervention in breast cancer cells

Service and Collaboration

Identification of new aberrantly expressed mirnas in intestinal-type gastric cancer and its clinical significance

mirna analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples

Genome-wide microrna profiling of human temporal lobe epilepsy identifies modulators of the immune response

CRS4 Seminar series. Inferring the functional role of micrornas from gene expression data CRS4. Biomedicine. Bioinformatics. Paolo Uva July 11, 2012

MicroRNA roles in signaling during lactation: an insight from differential expression, time course and pathway analyses of deep sequence data

Gene-microRNA network module analysis for ovarian cancer

Assaying micrornas in biofluids for detection of drug induced cardiac injury. HESI Annual Meeting State of the Science Session June 8, 2011

for Microbiology Quality Assessment Programmes for HPV and MRSA Effect of change to assessment categories for HBV DNA Dr Vivienne James SoGAT 2009

Obstacles and challenges in the analysis of microrna sequencing data

Original Article Identification of micrornas involved in Alzheimer s progression using a rabbit model of the disease

MicroRNA expression in ileal carcinoid tumors: downregulation of microrna-133a with tumor progression

Screening for novel oncology biomarker panels using both DNA and protein microarrays. John Anson, PhD VP Biomarker Discovery

starbase Pan-Cancer Tutorial

Mature microrna identification via the use of a Naive Bayes classifier


Identification of microrna-181a-5p and microrna-4454 as mediators of facet cartilage degeneration

Biofluid-based microrna Biomarkers for Parkinson's Disease: an Overview and Update

# of Normal brain # of controls Upregulated Downregulated Normalizer # of mirnas in Platform profile

Products for cfdna and mirna isolation. Subhead Circulating Cover nucleic acids from plasma

Identification of mirna-targeted cellular pathways in flavivirus-infected cells

SUPPLEMENTARY INFORMATION

RASA: Robust Alternative Splicing Analysis for Human Transcriptome Arrays

MicroRNA and Male Infertility: A Potential for Diagnosis

Integrated mirna and mrna Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

Transcription:

Benchmark study: Exiqon mircury LNA microrna arrays vs. Supplier A s DNA based capture probes Includes comparison of: I. II. III. Signal levels Relative quantification False differences For complete experimental set up, please see last slide

Comparison I: Signal levels Comparison of important micrornas All micrornas are robustly detected by the s More than half of the micrornas are undetected or poorly detected by from supplier A 8 Poor detection signal *Signal strength = log signal / amol target mir- mir-8a mir-55 mir- let-7a mir-5 mir- mir- mir- mir-9 Signal strenght [log]* Acceptable detection signal 6 Signals below log are considered under the detection limit whereas signals above 8 log are considered acceptable.

Comparison I: Signal levels Comparison of 66 micrornas With s more than 95% of all studied micrornas are reliably detected 8 Poor detection 5 6 micrornas 5 6 micrornas 6 Acceptable detection 8 Poor detection Signal strenght [log]* 6 Acceptable detection Signal strenght [log]* With DNA capture probes more than 5% of micrornas are either undetected or poorly detected *Signal strength = log signal / amol target Shown is the signal strength from the same 66 synthetic micrornas hybridized to Exiqon's mircury LNA microrna Array and Supplier A's DNA based array.

Comparison II: Relative quantification Comparison of important micrornas s ensures reliable detection of differences in expression for all micrornas TRUE - - - *See last slide for details mir-9 mir- mir- let-7a mir-55 mir-5 mir- mir-8a mir- - mir- Sample A / Sample B* DNA based capture probes from Supplier A show poor correlation between measured and actual differences

Comparison II: Relative quantification Comparison of all micrornas s ensures excellent correlation (R=.9) between expected and measured ratios from supplier A show poor correlation (R=.658) between expected and measured ratios 5-5 - - R² =,658-5 True ratio True ratio R² =,9-5 - - - - - - - - - -5-5 Measured ratio Measured ratio 5

Comparison III: False differences Comparison of 66 micrornas Exqon s array has a low rate of false differences while supplier A s array detects false difference for more than 5% of micrornas studied,5 Significant difference,5 -,5 - -,5 6 8 6 6 8 6,5 Significant difference Measured Ratio,5 Significant difference,5 -,5 - -,5 66 micrornas present in the same amount in sample A + B Significant difference Measured Ratio,5

Summary of benchmark study Comparison of all micrornas Exiqon s s ensures accurate results for all micrornas studied Supplier A s DNA based capture probes gives incorrect results for up to half of all micrornas studied % False differences 8 % 6 % * % of capture probes giving a signal above 8 log per amol synthetic microrna target. % ** % of capture probes that measure the correct ratio between sample A and B. (Correct ratio: log of the true ratio AND going in the same direction). % % Robust detection of mirnas* Reliable relative quantification of micrornas** Detection of false differences*** *** % of capture probes which has differences above,5 log or below -,5 log for microrna targets that were present in the same amounts in sample A and B.

Summary of benchmark study Experimental set-up Samples: Two complex samples of synthetic micrornas: Pool no sample A sample B (amol/ul) (amol/ul) log ratio 76.7.5 55.56.. 8. 66.67. 5 66.67. 6. 65.69.5 7.. 8.. 9.... 65.69. -.5 Data analysis:. 66.67 - Data analysis and determination of calls were done according to manufacturers recomendations. 66.67-8.. - 5. 55.56-6.5 76.7 - Each contain the same set of 7 micrornas (made up from 6 pools of up to 7 micrornas each) MicroRNAs are present at different concentrations in each sample A comparison of the samples gives different expected log ratios in the - to + range Protocol: Each sample labelled and hybirdised either to Exiqon s mircury LNA microrna array or Supplier A s array accordingto manufaturers instructions. Sample A and B have been used in previously published data: RNA (9), 5:8.